These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 29385054)

  • 1. A Preliminary Study for Evaluating the Dose-Dependent Effect of d-Allulose for Fat Mass Reduction in Adult Humans: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Han Y; Kwon EY; Yu MK; Lee SJ; Kim HJ; Kim SB; Kim YH; Choi MS
    Nutrients; 2018 Jan; 10(2):. PubMed ID: 29385054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. d-Allulose supplementation normalized the body weight and fat-pad mass in diet-induced obese mice via the regulation of lipid metabolism under isocaloric fed condition.
    Han Y; Han HJ; Kim AH; Choi JY; Cho SJ; Park YB; Jung UJ; Choi MS
    Mol Nutr Food Res; 2016 Jul; 60(7):1695-706. PubMed ID: 26920079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight loss and metabolic effects of topiramate in overweight and obese type 2 diabetic patients: randomized double-blind placebo-controlled trial.
    Eliasson B; Gudbjörnsdottir S; Cederholm J; Liang Y; Vercruysse F; Smith U
    Int J Obes (Lond); 2007 Jul; 31(7):1140-7. PubMed ID: 17264849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial.
    Ohara T; Muroyama K; Yamamoto Y; Murosaki S
    Nutr J; 2016 Jan; 15():6. PubMed ID: 26786000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. d-Allulose enhances postprandial fat oxidation in healthy humans.
    Kimura T; Kanasaki A; Hayashi N; Yamada T; Iida T; Nagata Y; Okuma K
    Nutrition; 2017; 43-44():16-20. PubMed ID: 28935140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare sugar D-psicose prevents progression and development of diabetes in T2DM model Otsuka Long-Evans Tokushima Fatty rats.
    Hossain A; Yamaguchi F; Hirose K; Matsunaga T; Sui L; Hirata Y; Noguchi C; Katagi A; Kamitori K; Dong Y; Tsukamoto I; Tokuda M
    Drug Des Devel Ther; 2015; 9():525-35. PubMed ID: 25632221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Sinetrol-XPur on Weight and Body Fat Reduction in Overweight or Obese Adults: A 12-Week, Randomized, Double-Blind, Parallel, Placebo-Controlled Trial.
    Park SJ; Sharma A; Bae MH; Sung HC; Kim NK; Sung E; Lee HJ
    J Med Food; 2020 Mar; 23(3):335-342. PubMed ID: 32130058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal Tolerance of D-Allulose in Healthy and Young Adults. A Non-Randomized Controlled Trial.
    Han Y; Choi BR; Kim SY; Kim SB; Kim YH; Kwon EY; Choi MS
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30572580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Euiiyin-tang in the treatment of obesity: study protocol for a randomised controlled trial.
    Cheon C; Jang S; Park JS; Ko Y; Kim DS; Lee BH; Song HJ; Song YK; Jang BH; Shin YC; Ko SG
    Trials; 2017 Jun; 18(1):289. PubMed ID: 28637494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of
    Kim CO; Kim YN; Lee DC
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31277301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Double-Blind, Randomized Controlled, Acute Feeding Equivalence Trial of Small, Catalytic Doses of Fructose and Allulose on Postprandial Blood Glucose Metabolism in Healthy Participants: The Fructose and Allulose Catalytic Effects (FACE) Trial.
    Braunstein CR; Noronha JC; Glenn AJ; Viguiliouk E; Noseworthy R; Khan TA; Au-Yeung F; Blanco Mejia S; Wolever TMS; Josse RG; Kendall CWC; Sievenpiper JL
    Nutrients; 2018 Jun; 10(6):. PubMed ID: 29890724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a High vs Moderate Volume of Aerobic Exercise on Adiposity Outcomes in Postmenopausal Women: A Randomized Clinical Trial.
    Friedenreich CM; Neilson HK; O'Reilly R; Duha A; Yasui Y; Morielli AR; Adams SC; Courneya KS
    JAMA Oncol; 2015 Sep; 1(6):766-76. PubMed ID: 26181634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Chungkookjang supplementation on obesity and atherosclerotic indices in overweight/obese subjects: a 12-week, randomized, double-blind, placebo-controlled clinical trial.
    Back HI; Kim SR; Yang JA; Kim MG; Chae SW; Cha YS
    J Med Food; 2011 May; 14(5):532-7. PubMed ID: 21434780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orlistat 60 mg reduces visceral adipose tissue: a 24-week randomized, placebo-controlled, multicenter trial.
    Smith SR; Stenlof KS; Greenway FL; McHutchison J; Schwartz SM; Dev VB; Berk ES; Kapikian R
    Obesity (Silver Spring); 2011 Sep; 19(9):1796-803. PubMed ID: 21720429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension.
    Tremblay A; Chaput JP; Bérubé-Parent S; Prud'homme D; Leblanc C; Alméras N; Després JP
    Eur J Clin Pharmacol; 2007 Feb; 63(2):123-34. PubMed ID: 17200837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial.
    Després JP; Ross R; Boka G; Alméras N; Lemieux I;
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):416-23. PubMed ID: 19112166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight reduction effects of a black soy peptide supplement in overweight and obese subjects: double blind, randomized, controlled study.
    Kwak JH; Ahn CW; Park SH; Jung SU; Min BJ; Kim OY; Lee JH
    Food Funct; 2012 Oct; 3(10):1019-24. PubMed ID: 22739624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial Effects of Supplementation of the Rare Sugar "D-allulose" Against Hepatic Steatosis and Severe Obesity in Lep(ob)/Lep(ob) Mice.
    Itoh K; Mizuno S; Hama S; Oshima W; Kawamata M; Hossain A; Ishihara Y; Tokuda M
    J Food Sci; 2015 Jul; 80(7):H1619-26. PubMed ID: 26012374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of sibutramine on blood glucose and lipids, body fat mass and insulin resistance in obese patients: a multi-center clinical trial].
    Tong NW; Ran XW; Li QF; Tang BD; Li R; Yang FY; Liu YP; Li XJ
    Zhonghua Nei Ke Za Zhi; 2005 Sep; 44(9):659-63. PubMed ID: 16202254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.